Miss Shila Renae Reeves, OTR, RN, BSN | |
3233 S Willis St, Abilene, TX 79605-6649 | |
(325) 692-4500 | |
(325) 692-4585 |
Full Name | Miss Shila Renae Reeves |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 3233 S Willis St, Abilene, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679612980 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 680322 (Texas) | Primary |
225X00000X | Occupational Therapist | 111635 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Miss Shila Renae Reeves, OTR, RN, BSN 55 Carriage Rd, Abilene, TX 79605-6546 Ph: (325) 695-7262 | Miss Shila Renae Reeves, OTR, RN, BSN 3233 S Willis St, Abilene, TX 79605-6649 Ph: (325) 692-4500 |
News Archive
On Wednesday, July 15, 2020, the Dietary Guidelines Advisory Committee (DGAC or Committee) - a group comprised of 20 nationally recognized health and nutrition experts - published the Scientific Report of the 2020 Dietary Guidelines Advisory Committee: Advisory Report to the Secretary of Agriculture and the Secretary of Health and Human Services.
In what is being seen as a victory for an abortion rights group, a federal judge in the United States has ruled that abortion clinic doctors and other professionals are not required under Kansas law to report report consensual sexual activity of those under 16 to authorities.
Tillotts Pharma AG, part of the Zeria Group, announced today that it has entered into an agreement for the acquisition of the global rights for Entocort (budesonide) from AstraZeneca, excluding the U.S., which will remain with AstraZeneca.
Bristol-Myers Squibb Company and ZymoGenetics, Inc. announced today that the companies have signed a definitive agreement providing for the acquisition of ZymoGenetics by Bristol-Myers Squibb, for $9.75 per share in cash.
A study from Imperial College London and Hammersmith Hospitals NHS Trust shows how a surveillance programme designed to monitor blood stream infections in dialysis units could cut the number of infections among patients.
› Verified 5 days ago